Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conheal artificial tears in Sjögren's syndrome dry eye
ISRCTN17717813Phase 2Completed
- Sponsor
- Semmelweis University
- Start
- Feb 2016
- Modality
- Bivalent/Multivalent Binders → Multivalent & Scaffold-Based Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of LO2A in dry eye syndrome (DED) and Sjögren's syndrome, sponsored by Semmelweis University. Primary endpoint: Change in ocular surface staining. Started Feb 2016; status: completed.
02
Drugs
LO2A
03
Conditions
dry eye syndrome (DED)Sjögren's syndrome
Beyond the preview
Go deeper on ISRCTN17717813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17717813.